Safety and tolerability of different total neoadjuvant therapy strategies in patients with locally advanced rectal cancer. First-in-human, phase 1a, dose escalation study of BGB-B167, a CEA x 4-1BB ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback